Impulse News

Impulse Dynamics Completes $45 million Financing Round

Stuttgart, May 11, 2017 – Impulse Dynamics, developer of the revolutionary Cardiac Contractility Modulation (CCM) technology for treatment of Chronic Heart Failure (CHF), announced today that the company has closed a $45 million financing round. The equity financing round was led by Goldstone Investment, a global investment company belonging to the Chinese conglomerate CITIC Securities, […]

Mehr dazu

Randomization of the FIX-HF-5C Confirmatory Study Completed

Orangeburg, New York, March 31, 2017 — Impulse Dynamics is pleased to announce that it has successfully completed enrollment of the 160 subjects required for its FIX-HF-5C Confirmatory Study. The FIX-HF-5C Study is a prospective, multicenter, randomized study to evaluate the safety and efficacy of cardiac contractility modulation (CCM) signals delivered by the implantable Optimizer […]

Mehr dazu

Going red to raise awareness of heart disease in women

Mt. Laurel, New Jersey, February 3 2017 Friday February 3rd saw women and men across the United States dressed in shades of red, from scarlet to crimson, for National Wear Red Day. February has been known as American Heart Month since the early 1960s, but in 2003 National Wear Red Day was introduced specifically to […]

Mehr dazu

CCM device makes a positive difference in life of chronic heart failure patient

Stuttgart – Diagnosed with chronic heart failure in 2009, Jürgen Schuller experienced recurrent hospital admissions and symptoms which seriously impaired his quality of life. Treatment via medication and an implantable cardioverter/defibrillator (ICD), although life-saving for many heart disease patients, failed to improve his condition. However, since receiving Impulse Dynamics’ OPTIMIZER device, Mr. Schuller has experienced […]

Mehr dazu

Impulse Dynamics Successfully Launches the Optimizer Smart Device for Heart Failure Treatment in Europe

Impulse Dynamics has launched the next generation of its Optimizer device, the Optimizer Smart, in Europe after it received the CE mark. The Optimizer Smart is a minimally invasive implantable device designed to treat chronic heart failure (CHF) in patients that are symptomatic despite appropriate medical therapy. The device is based on novel cardiac contractility […]

Mehr dazu
Seite 1 von 812345...Letzte »